Targeted temperature management (post-arrest)
TTM · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Controlled temperature after cardiac arrest for neuroprotection. Book era: induced hypothermia 32–34°C after VF arrest (HACA/Bernard 2002). 2020s practice: actively PREVENT FEVER (target ≤37.5–37.7°C) for ≥72 h; routine cooling to 33°C showed no outcome benefit vs 36°C (TTM 2013) or vs fever-avoidance (TTM2 2021).
Red flags
- Fever in the first 72 h post-arrest worsens outcome — treat aggressively
- Rewarming (if cooled) no faster than 0.25–0.5°C/h
Management
- Comatose after ROSC: sedate, ventilate to normoxia/normocapnia, MAP ≥65–70
- Continuous core temperature; use surface/intravascular devices to hold the target and PREVENT fever ≥37.8°C for at least 72 h
- Treat shivering: magnesium, counter-warming of hands/face, sedation, ± paralysis
- Watch during any cooling: bradycardia, hypokalaemia→rebound hyperkalaemia, hyperglycaemia, coagulopathy, infection risk
- Prognosticate no earlier than 72 h normothermic, multimodal (exam, NSE, EEG, SSEP, imaging)
The modern target is “no fever, tightly controlled” — device-driven temperature control with proper sedation.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.